Company Overview of Ocata Therapeutics, Inc.
Key Executives for Ocata Therapeutics, Inc.
|Masao Yoshida||13 Relationships||Chief Executive Officer, President and Director||--|
|Stephen Knowles||13 Relationships||Treasurer and Director||--|
|Linda Friedman J.D.||13 Relationships||Secretary and Director||--|
|John Heffernan||No Relationships||Vice President of Manufacturing||--|
|Matthew Vincent Ph.D.||No Relationships||Director of Business Development||--|
Ocata Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Masao Yoshida||13 Relationships||Ocata Therapeutics, Inc.||--|
|Stephen Knowles||13 Relationships||Ocata Therapeutics, Inc.||--|
|Linda Friedman J.D.||13 Relationships||Astellas Pharma, Inc.||--|
|Ronald M. Green Ph.D.||13 Relationships||Ocata Therapeutics, Inc.||--|
|Robert S. Langer Jr., Ph.D., Sc.D.||520 Relationships||PureTech Health plc||67|
Ocata Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board Jr., Ph.D., Sc.D.||Robert S. Langer||520 Relationships||10 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.